SFX by Ex Libris Inc.

Title:	Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants
Source:	Nature Genetics [1061-4036] Pasquali, Lorenzo yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ciriello, G. "Emerging landscape of oncogenic signatures across human cancers." Nature Genetics 45.10 (2013): 1127-1133.
description	2.	Abecasis, S. "Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes." Nature Genetics 44.9 (2012): 981-990.
description	3.	Hearn, T.. "Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes." Diabetes 54.5 (2005): 1581-1587.
description	4.	Roberts, Jennifer A. "Targeted transgene integration overcomes variability of position effects in zebrafish." Development 141.3 (2014): 715-724.
description	5.	Raeder, Helge, Pål Rasmus R. "Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction." Nature genetics 38.1 (2006): 54-62.
description	6.	Kahn, Steven E. "Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future." Lancet (London, England) 383.9922 (2013): 1068-1083.
description	7.	Prentki, M. "Type 2 diabetes across generations: from pathophysiology to prevention and management." Lancet 378.9786 (2011): 169-81.
description	8.	Beroukhim, M. "Pan-cancer patterns of somatic copy number alteration." Nature Genetics 45.10 (2013): 1134-1140.
description	9.	Kearney, Mark T. "Changing the Way We Think About Endothelial Cell Insulin Sensitivity, Nitric Oxide, and the Pathophysiology of Type 2 Diabetes: The FoxO Is Loose." Diabetes 62.5 (2013): 1386-1388.
description	10.	Campbell, RK. "Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies." Journal of family practice 59.9 (2010).
description	11.	Oshlack, A. "From RNA-seq reads to differential expression results." GenomeBiology.com 11.12 (2010): 220-220.
description	12.	Spellman, Craig W. "Pathophysiology of type 2 diabetes: targeting islet cell dysfunction." The Journal of the American Osteopathic Association 110.3 Suppl 2 (2010): 2-7.
description	13.	Keats, Jonathan J J. "In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression." Blood 101.4 (2003): 1520-9.
description	14.	Heng, H. "Cancer progression by non-clonal chromosome aberrations." Journal of cellular biochemistry 98.6 (2006): 1424-1435.
description	15.	Del Guerra, S. "Functional and molecular defects of pancreatic islets in human type 2 diabetes." Diabetes 54.3 (2005): 727-735.
description	16.	Scherer, Stephen W W. "Challenges and standards in integrating surveys of structural variation." Nature genetics 39.7 Suppl (2007): 7-15.
description	17.	Subedi, A. "Adoption of the Q transcriptional regulatory system for zebrafish transgenesis." Methods 66.3 (2014): 433-440.
description	18.	Müller, N. "Redefining the initiation and maintenance of zebrafish interrenal steroidogenesis by characterizing the key enzyme cyp11a2." Endocrinology 154.8 (2013): 2702-11.
description	19.	Kristinsson, S Y. "MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1." Diabetologia 44.11 (2001): 2098-103.
description	20.	Knöchel, W. "Globin evolution in the genus Xenopus: comparative analysis of cDNAs coding for adult globin polypeptides of Xenopus borealis and Xenopus tropicalis." Journal of molecular evolution 23.3 (1986): 211-23.